EMA pharmacovigilance committee initiates first EU-wide drug safety review
This article was originally published in Scrip
Executive Summary
The European Medicines Agency's newly formed pharmacovigilance committee has begun its first EU-wide drug safety review by looking to address concerns with codeine-containing medicines used for post-operative pain relief in children.